[1] 陈海艳,周惠敏,吴波,等.糖尿病对细菌性肝脓肿患者并发脓毒症的影响.中华肝胆外科杂志,2023,29(8):567-572. [2] Wang JL, Hsu CR, Wu CY, et al. Diabetes and obesity and risk of pyogenic liver abscess. Sci Rep,2023,13(1):7922-7925. [3] Markers D. Retracted: clinical characteristics of diabetes complicated by bacterial liverabscess and nondiabetes-associated liver abscess. Dis Markers,2023,7(19):732-739. [4] Wang F, Yu J, Chen W, et al. Clinical characteristics of diabetes complicated by bacterial liver abscess and nondiabetes-associated liver abscess. Dis Markers,2022,4(26):7512-7516. [5] 郑浩,王洪剑,刘晶晶.肺炎克雷伯菌肝脓肿患者临床特征分析.实用肝脏病杂志,2024, 27(1):121-124. [6] 中华医学会外科学分会,中国研究型医院学会感染性疾病循证与转化专业委员会,中华外科杂志编辑部.外科常见腹腔感染多学科诊治专家共识.中华外科杂志,2021,59(3): 161-178. [7] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版).中华糖尿病杂志,2021,13(4):315-409. [8] Song H, Wang X, Lian Y, et al. Analysis of the clinical characteristics of 202 patients with liver abscess associated with diabetes mellitus and biliary tract disease. J Int Med Res,2020, 48(8):404-407. [9] Wang TY, Lai HC, Chen HH, et al. Pyogenic liver abscess risk in patients with newly diagnosed type 2 diabetes mellitus: a nationwide, population-based cohort study. Front Med,2021,12(8):6753-6755. [10] Du Z, Zhou X, Zhao J, et al. Effect of diabetes mellitus on short-term prognosis of 227 pyogenic liver abscess patients after hospitalization. BMC Infect Dis,2020,20(1):145-147. [11] Molton JS, Chan M, Kalimuddin S, et al. Oral vs intravenous antibiotics for patients with klebsiella pneumoniae liver abscess: a randomized, controlled noninferiority study. Clin Infect Dis,2020,71(4):952-959. [12] Hamide A, Mahapatra R, Noronha AK, et al. Hypervirulent Klebsiella pneumoniae infection presenting as endocarditis and liver abscess. Trop Doct,2022,52(4): 583-585. [13] Aguilar D, Duran J, López LE, et al. Klebsiella pneumoniae K2 producer of pyogenic liver abscess associated with biliary communication. J Infect Dev Ctries,2022,16(9):1524-1529. [14] Lee SC, Kim SJ, Yu MH, et al. Uses of Inflammatory Markers for Differentiation of Intrahepatic Mass-Forming Cholangiocarcinoma from Liver Abscess: Case-Control Study. J Clin Med,2020,9(10):3194-3196. [15] Malik IA, Ramadori G. Interleukin-6-Production Is Responsible for Induction of Hepatic Synthesis of Several Chemokines as Acute-Phase Mediators in Two Animal Models: Possible Significance for Interpretation of Laboratory Changes in Severely Ill Patients. Biology (Basel),2022,11(3):470-472. [16] Rakholia R, Rawat V, Maroof M. Liver abscess in children-Clinical profile and outcome in a resource-limited setting. J Family Med Prim Care,2022,11(11): 7289-7293. [17] Meister P, Irmer H, Paul A, et al. Therapy of pyogenic liver abscess with a primarily unknown cause. Langenbecks Arch Surg,2022,407(6):2415-2422. [18] Han S, Ye Y, Wu J, et al. Procalcitonin Levels in Post TACE Infection. Cancer ManagRes,2020,26(12):12197-12203. [19] 宁月季,成家飞,钱佶,等.2型糖尿病与非2型糖尿病患者发生细菌性肝脓肿临床特征分析.实用肝脏病杂志,2023,26(5):730-733. [20] Sayaghi KM, Alhujaily M, Zaky MK, et al. Percutaneous needle aspiration versus catheter drainage in the management of liver abscess: an updated systematic review and meta-analysis. ANZ J Surg,2023,93(4):840-850. [21] Pu D, Zhao J, Chang K, et al. Superbugs" with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China.Sci Bull (Beijing), 2023, 68(21):2658-2670. [22] Chen Y, Gong Y, Song B, et al. Pyogenic liver abscess complicated with endogenous endophthalmitis caused by Klebsiella pneumoniae: A case report and Literature Review.Immun Inflamm Dis, 2023,11(7):e943. [23] Kocsis B.Hypervirulent Klebsiella pneumoniae: An update on epidemiology, detection and antibiotic resistance.Acta Microbiol Immunol Hung, 2023,70(4):278-287. [24] Yoong J, Yuen KH, Molton JS, et al. Cost-minimization analysis of oral versus intravenous antibiotic treatment for Klebsiella pneumoniae liver abscess.Sci Rep, 2023,13(1):9774. |